manufacturer's instructions. Abundances of gene copies of 16S rRNA and seven tet genes (tetA, tetB, tetG, tetM, tetO, tetQ, and tetW) were quantified by qPCR.
The primers were obtained from Integrated DNA Technologies (Coralville, Iowa), and the dual-labeled black hole quencher probes for the 16S rRNA assay were from Biosearch Technologies, Inc. (Petaluma, CA). The assays were performed in Qiagen HotStarTaq Master Mix (Qiagen, Valencia, CA) for TaqMan TM probe assays, and QuantiTect SYBR green master mix (Qiagen) for SYBR assays in a total reaction volume of 25 µL. The assay consisted of 12.5 µL of the reaction mix, 1.5 µL of 10 µM (600 nM total primer concentration) each of the forward and reverse primers, 1 µL (100 nM total probe concentration) of probe, 1.5 µL of 25 mM MgCl2 (for 16S rRNA only), 5 µL of 1:100 diluted sample DNA (diluted in 1:100 ratio to reduce potential PCR inhibitors) or the standard (ranging from 10 1 to 10 8 copies), and 2 µL (for 16S rRNA only) or 4.5 µL (for SYBR assays) of water. Typical qPCR reactions consisted of initial activation at 95°C for 15 min, 40 cycles of denaturation at 95°C for 15 s and held at annealing temperature for 20 s, followed by final extension at 72°C for 30 s. Melt curve analysis was conducted between 65°C to 95°C with an increment of 0.2°C for 1 s. All qPCR reactions were run on the Bio-Rad CFX 96 real-time PCR detection system (Bio-Rad, Hercules, CA).
Analysis of Tetracycline Antibiotics Chemicals
Tetracycline (≥98.0% HPLC purity), oxytetracycline hydrochloride (≥95.0% purity), chlortetracycline hydrochloride (≥75.0% purity), and 4-epitetracycline hydrochloride (≥95.0% purity) were purchased from Sigma Aldrich (St. Louis, MO); demeclocycline hydrochloride (used as a recovery standard) was purchased from Alfa Aesar (Haverhill, MA), while isochlortetracycline hydrochloride was purchased from Toronto Research Chemicals (North York, ON, Canada). All solvents (methanol, acetonitrile, and water) were of HPLC or LC-MS grades and were purchased from Sigma Aldrich. Sodium dihydrogen phosphate, ethylene diamine tetra-acetic acid disodium salt (Na2-EDTA), citric acid monohydrate (all reagent grade)
were purchased from Sigma Aldrich. Standards of all chemicals were individually dissolved in methanol and then mixed to prepare calibration curves ranging from 0.1 to 2 µg/mL.
Sample Extraction
Tetracycline antibiotics (chlortetracycline, oxytetracycline, and tetracycline) and their transformation products (4-epitetracycline and isochlortetracycline) were extracted from the anaerobic digester samples. Briefly, 10 mL of each sample was transferred into a 50-mL centrifuge tube, spiked with 100 µL of a 10 µg/mL of the recovery standard demeclocycline (DMC), and then followed by an addition of 10 mL of methanol and 10 mL of a 0.2 M EDTAMcIlvaine buffer, pH 4.0 solution. The sample was vortexed for 30 s, sonicated for 15 min. and vortexed again for 30 s. Next, the sample was centrifuged at a relative centrifugal force (rcf) of 3260 g for 10 min, and the supernatant was decanted into a 50-mL beaker. The pH of the supernatant was adjusted to pH 4.0 using concentrated sulfuric acid. Digester samples less than 10 mL in volume, were extracted without a volume adjustment.
The samples were then cleaned using weak cation exchange polymeric solid phase extraction (SPE) cartridges (Strata-X-CW, 500 mg, 6 mL, Supelco, Bellefonte, PA). The cartridges were first conditioned with 10 mL of methanol followed by 10 mL of DI water. After conditioning, the extracts were passed through the cartridges at a flow rate of 1 mL/min. The cartridges were washed with 20 mL of a methanol: water (10:90) solvent mixture, followed by 10 mL of methanol and then dried by air suction for 20 min. The tetracyclines were eluted with 6 mL (2 × 3 mL) of 0.1 M citric acid in 95% methanol. The eluents were evaporated to dryness at 50 o C under a gentle stream of nitrogen gas. The dry extracts were reconstituted in 1 mL of methanol, filtered with a 0.22 µm nylon filter, and transferred to 2 mL glass vials for LC-MS/MS analysis.
LC-MS/MS Analysis
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